PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice. (2023)

First Author: Kordala AJ
Attributed to:  Antisense Oligonucleotide Therapy for Neuromuscular Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.15252/emmm.202317683

PubMed Identifier: 37724723

Publication URI: http://europepmc.org/abstract/MED/37724723

Type: Journal Article/Review

Volume: 15

Parent Publication: EMBO molecular medicine

Issue: 11

ISSN: 1757-4676